A GMO Experiment on Two-Thirds of the World’s Population: Reaction to Ulrich’s Commentary on Lee and Broudy (2024)

Authors

  • Tamara Tuuminen Adjunct Professor, consultant in Medical Microbiology, Medical Centre Kruunuhaka Oy, Helsinki, Finland

DOI:

https://doi.org/10.56098/xncqaa94

Keywords:

genetic experimentation on humans, human GMOs, human gut biota, lipid nanoparticles, COVID-19 modified mRNA vaccines, Moderna mRNA vaccine, Pfizer mRNA vaccine, self-assembling structures

Abstract

While Professor A. Ulrich (2024) raised justifiable questions about the interpretation of microscopic images from incubated COVID-19 injectables from Pfizer and Moderna, her message treats the world-wide genetic modification experiment with COVID-19 injectables on humans — an experiment on us without our consent — as normal. I will not discuss the physico-chemistry of the 10 trillion lipid nanoparticles she claims are in every dose of the injectables. She acknowledges that “many of the lipid constituents . . . tend to induce inflammation” (p. 1244.3) but says they account for all the self-assembling structures documented in what she describes as the “reliable” and “fully consistent” findings (Ulrich, p. 1244.7) of Lee and Broudy (2024). Though I believe the self-assembling structures also merit in-depth study, the technology underlying them, must be contained in the concoctions injected into the arms of two-thirds of the world’s population without proper preclinical testing and without the informed consent required by the Nuremberg Code. My focus is on that violation of medical ethics turning humans into genetically modified organisms. Here I illustrate in her words that such a genetic experiment on humans is underway. Instead of refuting any of the evidence in Lee and Broudy (2024) —that whatever the injectables may actually contain they are harming the human population of the world — she actually admits in closing that those “risks will be exacerbated with the next generation of self-amplifying or self-replicating RNA vectors for vaccines” (1244.8).

Author Biography

  • Tamara Tuuminen, Adjunct Professor, consultant in Medical Microbiology, Medical Centre Kruunuhaka Oy, Helsinki, Finland

    MD, PhD, Adjunct professor and specialist in clinical microbiology consulting for the last 5 years, 2019 to 2024, at Kruunuhaka Medical Centre, Helsinki, and Mineraalilaboratorio Mila, Helsinki; she graduated in 1979 from the First Moscow Medical Institute with an MD specializing in hygiene and epidemiology; for 14 years, 1986 to 2000, she worked at Labsystems Diagnostics Oy; she earned a PhD from the University of Helsinki in 1993 and taught medical microbiology including virology, bacteriology, and immunology there from 2000 to 2010; she also practiced medical microbiology from 2000 until 2019. During her 14 years at Labsystems, working as the Technology and Project Manager, she made advances in screening neonates for phenylketonuria and congenital hypothyroidism, concerning which she also wrote her dissertation; at Labsystems she also developed tests used with children and adults to diagnose Chlamydia pneumoniae and Mycoplasma pneumoniae; she also developed tests for congenital toxoplasmosis; and made advances in tuberculosis immunodiagnostics; during her decade at the University of Helsinki she made advances in the detection and treatment of moldrelated illness and clinical immunonutrition while also supervising graduate students in bioanalytics at the master’s and doctoral levels. Over her career she has published nearly 100 original articles and reviews in international and Finnish medical journals. Tuuminen holds four patents and formerly served as Chief Physician in Mikkeli Central Hospital (Finland) in microbiology. 

References

Benzi Cipelli, R., Giovannini, F., & Pisano, G. (2022). Dark-field microscopic analysis on the blood of 1,006 symptomatic persons after anti-COVID mRNA injections from Pfizer/BioNtech or Moderna. International Journal of Vaccine Theory, Practice, and Research, 2(2), 385–444. https://doi.org/10.56098/ijvtpr.v2i2.47

Cabanillas, B., Akdis, C. A., & Novak, N. (2021). COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: “COVID-19 vaccine anaphylaxis: PEG or not?” Allergy, 76(6), 1938–1940. https://doi.org/10.1111/all.14725

Chen, S. P., & Blakney, A. K. (2024). Immune response to the components of lipid nanoparticles for ribonucleic acid therapeutics. Current Opinion in Biotechnology, 85, 103049. https://doi.org/10.1016/j.copbio.2023.103049

Children’s Health Defense. (2020, December 14). FDA Ignores RFK, Jr.’s Pleas for Vaccine Safety Oversight Concerning PEG, Suspected To Cause Anaphylaxis. https://www.prnewswire.com/news-releases/fda-ignores-rfk-jrs-pleas-for-vaccine-safety-oversight-concerning-peg-suspected-to-cause-anaphylaxis-301192173.html

Commissioner, O. of the. (2024). Emergency Use Authorization. FDA. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization

European Commission. (2024). Q&A: Conditional Marketing Authorisation of COVID-19 Vaccine [Text]. European Commission - European Commission. https://ec.europa.eu/commission/presscorner/detail/en/qanda_20_2390

Ghebreyesus, T. A. (2020, March 11). WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023). A comprehensive review of mRNA vaccines. International Journal of Molecular Sciences, 24(3), Article 3. https://doi.org/10.3390/ijms24032700

Guetzkow, J. (2023, January 4). CDC Finally Released Its VAERS Safety Monitoring Analyses for COVID Vaccines via FOIA [Substack newsletter]. Jackanapes Junction. https://jackanapes.substack.com/p/cdc-finally-released-its-vaers-safety?publication_id=747747&isFreemail=true

Hughes, D. A. (2021). “COVID-19 vaccines” for children in the UK: A tale of establishment corruption. International Journal of Vaccine Theory, Practice, and Research, 2(1), 209–247. https://doi.org/10.56098/ijvtpr.v2i1.35

Hughes, D. A. (2022). What is in the so-called COVID-19 “vaccines”? Part 1: evidence of a global crime against humanity. International Journal of Vaccine Theory, Practice, and Research, 2(2), 455–586. https://doi.org/10.56098/ijvtpr.v2i2.52

Hughes, D. A. (2024). “COVID-19,” Psychological Operations, and the War for Technocracy: Volume 1. Springer International Publishing. https://doi.org/10.1007/978-3-031-41850-1

Kirsch, S., Marik, P., Rogers, C., Cosgrove, K., & Mead, M. N. (2024). A Novel Practical Approach for Directly Assessing COVID-19 Vaccine Efficacy against Hospitalization (2024080338). Preprints. https://doi.org/10.20944/preprints202408.0338.v1

Lee, Y. M., & Broudy, D. (2024). Real-time self-assembly of stereomicroscopically visible artificial constructions in incubated specimens of mRNA products mainly from Pfizer and Moderna: A comprehensive longitudinal study. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1180–1244. https://doi.org/10.56098/586k0043

Mead, M. N., Seneff, S., Rose, J., Wolfinger, R., McCullough, P. A., & Hulscher, N. (2024). COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1246–1315. https://doi.org/10.56098/w66wjg87

Mead, M. N., Seneff, S., Wolfinger, R., Rose, J., Denhaerynck, K., Kirsch, S., & McCullough, P. A. (2024). COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1112–1178. https://doi.org/10.56098/fdrasy50

Nance, K. D., & Meier, J. L. (2021). Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines. ACS Central Science, 7(5), 748–756. https://doi.org/10.1021/acscentsci.1c00197

Rose, J., & McCullough, P. A. (2021). A report on myocarditis adverse events in the US Vaccine Adverse Events Reporting System (VAERS) in association with COVID-19 injectable biological products. Current Problems in Cardiology, 101011. https://doi.org/10.1016/j.cpcardiol.2021.101011

Santiago, D. (2022). A partial answer to the question posed by David A. Hughes, PhD, in the article: “What is in the so-called COVID-19 ‘vaccines’? Part 1: evidence of a global crime against humanity.” International Journal of Vaccine Theory, Practice, and Research, 2(2), 587–594. https://doi.org/10.56098/ijvtpr.v2i2.56

Seneff, S., & Nigh, G. (2021). Worse than the disease? Reviewing some possible unintended consequences of the mRNA vaccines against COVID-19. International Journal of Vaccine Theory, Practice, and Research, 2(1), 38–79. https://doi.org/10.56098/ijvtpr.v2i1.23

Shimabukuro, T. T., Cole, M., & Su, J. R. (2021). Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021. JAMA. https://doi.org/10.1001/jama.2021.1967

Smout, A. (2020, December 10). Britain issues anaphylaxis warning on Pfizer vaccine after adverse reactions. Japan Today. https://japantoday.com/category/world/Britain-issues-anaphylaxis-warning-on-Pfizer-vaccine-after-adverse-reactions

Sobczak, M., & Pawliczak, R. (2022). The risk of anaphylaxis behind authorized COVID-19 vaccines: A meta-analysis. Clinical and Molecular Allergy, 20(1), 1. https://doi.org/10.1186/s12948-022-00167-y

Tuuminen, T., Suominen, P. J., & Guldbrandsen, T. A. (2023). A Finnish Survey of Adverse Effects of COVID-19 Injectables and the Functionality of the Medical System. International Journal of Vaccine Theory, Practice, and Research, 3(1), 1009–1025. https://doi.org/10.56098/ijvtpr.v3i1.87

Ulrich, A. S. (2024). No Nanobots in Vaccines — Just Lipids on the Loose: Commentary on Lee and Broudy (2024), “Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructs in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitundinal Study.” International Journal of Vaccine Theory, Practice, and Research, 3(2), 1244.1-1244.10. https://doi.org/10.56098/7hsjff81

Downloads

Published

2024-09-14

How to Cite

A GMO Experiment on Two-Thirds of the World’s Population: Reaction to Ulrich’s Commentary on Lee and Broudy (2024). (2024). International Journal of Vaccine Theory, Practice, and Research , 3(2), 1244.11-1244.18. https://doi.org/10.56098/xncqaa94

Similar Articles

1-10 of 60

You may also start an advanced similarity search for this article.